Literature DB >> 17944667

Mucosal graft-vs-host disease.

J Lew1, J A Smith.   

Abstract

Graft-vs-host disease (GVHD) is a serious complication of hematopoietic stem cell transplantation (HSCT). Indications for HSCT have greatly expanded, and more patients are undergoing HSCT today than ever before. In addition, the options for immunosuppressive therapy for both prevention and treatment of GVHD have also expanded. These changes have in turn altered the landscape of this disease. We have reviewed the current literature on this subject and presented an update on this disease with a particular emphasis on mucosal manifestations.

Entities:  

Mesh：

Year:  2007        PMID： 17944667     DOI： 10.1111/j.1601-0825.2007.01412.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN： 1354-523X            Impact factor:   3.511


  5 in total

Review 1.  Oral graft-versus-host disease.

Authors:  M M Imanguli; I Alevizos; R Brown; S Z Pavletic; J C Atkinson
Journal:  Oral Dis       Date:  2008-07       Impact factor: 3.511

Review 2.  Autoimmunity at the ocular surface: pathogenesis and regulation.

Authors:  M E Stern; C S Schaumburg; R Dana; M Calonge; J Y Niederkorn; S C Pflugfelder
Journal:  Mucosal Immunol       Date:  2010-05-19       Impact factor: 7.313

3.  Oral complaints and dental care of haematopoietic stem cell transplant patients: a qualitative survey of patients and their dentists.

Authors:  Jacolien Bos-den Braber; Carin M J Potting; Ewald M Bronkhorst; Marie-Charlotte D N J M Huysmans; Nicole M A Blijlevens
Journal:  Support Care Cancer       Date:  2014-06-08       Impact factor: 3.603

4.  Functional salivary reservoir in maxillary complete denture - technique redefined.

Authors:  Angel Mary Joseph; Suja Joseph; Nicholas Mathew; Ashwin Thomas Koshy
Journal:  Clin Case Rep       Date:  2016-10-11

5.  International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I).

Authors:  Yoko Ogawa; Stella K Kim; Reza Dana; Janine Clayton; Sandeep Jain; Mark I Rosenblatt; Victor L Perez; Hasanain Shikari; Anjo Riemens; Kazuo Tsubota
Journal:  Sci Rep       Date:  2013-12-05       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.